Abstract

Previous meta–analyses of percutaneous coronary intervention (PCI) with drug–eluting stent (DES) versus coronary artery bypass grafting (CABG) for unprotected left main coronary artery disease (ULMCAD) have abstracted (and then combined) unadjusted risk estimates from not only a few randomized

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call